Nasdaq Anix News Today

HC Wainwright reaffirmed their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $12.00 price objective on the stock. HC Wainwright also issued estimates for Anixa Biosciences’ FY2025 earnings at ($0.40) EPS. Anixa Biosciences Price Performance […]

HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a report issued on Thursday morning, Benzinga reports. The brokerage currently has a $12.00 target price on the stock. Anixa Biosciences Price Performance Shares of Anixa Biosciences stock opened at $4.08 on Thursday. Anixa Biosciences has a fifty-two week […]

HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $12.00 target price on the stock. Separately, TheStreet lowered Anixa Biosciences from a c- rating to a d rating in a research note on Friday, June 16th. […]

Anixa Biosciences, Inc. (NASDAQ:ANIX – Get Free Report) was the recipient of a significant decline in short interest in July. As of July 31st, there was short interest totalling 663,000 shares, a decline of 6.0% from the July 15th total of 705,300 shares. Based on an average daily volume of 88,000 shares, the days-to-cover ratio […]

HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report report published on Friday morning, Benzinga reports. They currently have a $12.00 price target on the stock. Separately, TheStreet cut shares of Anixa Biosciences from a c- rating to a d rating in a research note […]

Chardan Capital reaffirmed their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Get Rating) in a research report report published on Wednesday, MarketBeat Ratings reports. They currently have a $9.00 target price on the stock, up from their previous target price of $8.00. Chardan Capital also issued estimates for Anixa Biosciences’ FY2024 earnings at […]

Chardan Capital reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Get Rating) in a research note published on Wednesday morning, Marketbeat.com reports. They currently have a $9.00 target price on the stock, up from their previous target price of $8.00. Chardan Capital also issued estimates for Anixa Biosciences’ FY2024 earnings at $4.61 […]

Anixa Biosciences, Inc. (NASDAQ:ANIX – Get Rating) – Stock analysts at Chardan Capital issued their FY2024 EPS estimates for shares of Anixa Biosciences in a research note issued on Wednesday, March 22nd. Chardan Capital analyst M. Barcus forecasts that the company will post earnings per share of $4.61 for the year. Chardan Capital has a […]

Anixa Biosciences (NASDAQ:ANIX – Get Rating) had its target price lifted by HC Wainwright from $11.00 to $12.00 in a research note released on Thursday morning, The Fly reports. The firm currently has a buy rating on the stock. Separately, Chardan Capital upped their price objective on shares of Anixa Biosciences from $8.00 to $9.00 […]

Anixa Biosciences (NASDAQ:ANIX – Get Rating) and ASLAN Pharmaceuticals (NASDAQ:ASLN – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Earnings and Valuation This table compares Anixa Biosciences and […]